Annual TB Conference: Toward Zero TB
 
Conference Course ID: 1041933
Start Date: 03/22/2013
End Date: 03/22/2013
Registration Deadline: 03/19/2013
Time Zone: ET
Conference Description:
Annual TB Conference: "Toward Zero TB"
March 22, 2013
8:30AM - 4:00PM
42-09 28th Street
Gotham Center, Auditorium, Room 03-32
Long Island City, New York 11101-4132


CME/CNE Certified Activity

Jointly Sponsored By
New York City Department of Health & Mental Hygiene Bureau of TB Control,
NJMS Global Tuberculosis Institute,
UMDNJ - Center for Continuing & Outreach Education

This activity is supported in part by an educational grant from the Centers for Disease Control and Prevention, Division of Tuberculosis Elimination

The New Jersey Medical School Global Tuberculosis Institute is the Tuberculosis Regional Training and Medical Consultation Center for the Northeast United States

 
COURSE DESCRIPTION & OVERALL GOAL

In commemoration of World TB Day, this conference will address TB prevention and control efforts in New York City to highlight progress in the fight against TB. Topics will include historical and current perspectives for addressing drug resistant TB, new modalities in the diagnosis and treatment of TB, ethical aspects of treating TB, updates in the management of TB-HIV co-infection, and taking steps to address TB among the foreign born.  

WHO SHOULD ATTEND

This conference is open to providers (pulmonary, infectious disease, community health, infection control) and health care workers who manage patients at risk for or diagnosed with TB. 

WHY COURSE IS NEEDED

The management of TB requires a multidisciplinary approach which relies on knowledge of the current TB rates, populations at risk and interventions that are successful. This conference will provide updates on new and emerging issues in the diagnosis and treatment of tuberculosis as well as facilitate discussion among colleagues.

OBJECTIVES

Upon completion of this conference, participants will be able to:

  • Discuss ethical issues related to the prevention, treatment and control of tuberculosis and programmatic readiness to meet common ethical challenges
  • Utilize local epidemiology of TB and health needs assessment results to inform ongoing BTBC efforts to generate and strengthen partnerships toward reducing TB
  • Discuss the need for new drugs that offer shorter, simpler, safer TB treatment regimens
  • Explain the benefits and limitations of molecular tests for the diagnosis of TB and detection of drug resistance in M. tb complex
  • Review current recommendations for the effective management of TB and HIV co-infection
  • Discuss the historical, biological and social context of drug-resistant tuberculosis in the U.S. and globally, including current gaps in efforts to stem tuberculosis
  • Describe the rationale behind a new orientation and strategy for the global struggle against tuberculosis

COURSE REQUIREMENTS

In order to meet the learning objectives and receive continuing education credits, participants are required to register in advance, attend the entire conference, and complete an online evaluation.

FACULTY

Karen Brudney, MD
Director, Infectious Disease/AIDS Clinic
Director, TB Service
New York-Presbyterian Hospital

Joseph Burzynski, MD, MPH
Assistant Commissioner/Director, Bureau of Tuberculosis Control
New York City Department of Health & Mental Hygiene

Salmaan Keshavjee, MD, PhD, ScM
Associate Professor, Department of Global Health & Social Medicine
Harvard Medical School

Jennifer Rakeman, PhD
Assistant Commissioner
Public Health Laboratory
New York City Department of Health & Mental Hygiene

Lee Reichman, MD, MPH
Executive Director
New Jersey Medical School Global Tuberculosis Institute

Neil Schluger, MD
Chief, Division of Pulmonary, Allergy & Critical Care Medicine
Professor of Medicine, Epidemiology & Environmental Sciences
Columbia University


AGENDA

8:30am   Registration

9:00am   Opening Remarks/Epidemiology of TB in NYC
                   Joseph Burzynski, MD, MPH

9:15am   Keynote Address: From the New York 
              epidemic to the movement for zero TB 
              deaths: What lessons have we learned?
                   Salmaan Keshavjee, MD, PhD, ScM

10:15am  Break

10:30am  Video:“Surviving MDR-TB: My Story My Voice

10:45am  Eliminating Tuberculosis Ethically
                    Lee Reichman, MD, MPH

11:30am  TB and HIV Update
                    Karen Brudney, MD

12:15pm Questions and Answers

12:30pm  Lunch

1:30pm   Emerging New Therapies for TB
                    Neil Schluger, MD

2:30pm   New Molecular Diagnostic Tools for M.
             tuberculosis
                   Jennifer Rakeman, PhD

3:00pm   Break

3:15pm   Engaging Patients, Providers & Communities 
             to Eliminate TB in NYC
                  Joseph Burzynski, MD, MPH

3:45pm   Questions & Answers

4:00pm   Closing Remarks

CONTINUING EDUCATION INFORMATION

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of NJMS Global Tuberculosis Institute, New  York City Department of Health and Mental Hygiene Bureau of TB Control, and UMDNJ – Center for Continuing and Outreach Education. UMDNJ – Center for Continuing and Outreach Education is accredited by the ACCME to provide continuing medical education for physicians.
UMDNJ – Center for Continuing and Outreach Education designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

UMDNJ-Center for Continuing and Outreach Education is an approved provider of continuing nursing education by NJSNA, an accredited approver by the American Nurses Credentialing Center's COA. Provider Number P173-12/12-15.

This activity is awarded 5.5 contact hours (60 minute CH).
Nurses should only claim those contact hours actually spent participating in the activity.

Approved provider status refers only to continuing education activities and does not imply ANCC COA or NJSNA endorsement of any commercial products.

DISCLOSURE POLICY

It is the policy of the UMDNJ – Center for Continuing and Outreach Education that all speakers and planners disclose any real or apparent conflicts of interest related to the content of this educational activity and also disclose discussions of off-label or investigational uses of drugs or devices during their presentation(s). These disclosures will be made in the activity handout materials.

REGISTRATION INFORMATION & FEE

The deadline for registration is March 11, 2013.

Registration priority will be given to applicants from the Greater NYC Area. We reserve the right to close registration early or cancel late registrants due to limits on seating capacity.

There is no fee for this conference. However, if you register and are unable to attend, we ask that you inform us as soon as possible so that others may be accommodated.

CANCELLATION INFORMATION

UMDNJ reserves the right to modify the activity content, faculty and activities, and reserves the right to cancel this activity, if necessary.

For additional program information, questions, or if you require special arrangements to attend this conference, please contact DJ McCabe at 973-972-0978 or by email at mccabedj@umdnj.edu

Certificate: N/A
Sponsor: NJMS Global Tuberculosis Institute, New York City Department of Health & Mental Hygiene Bureau of Tuberculosis, UMDNJ Center for Continuing & Outreach Education
Core Competencies: N/A
Help | Contact | © PHF 2003-2014- Confidentiality Statement | Powered By KMi inc.
Font Options: Zoom In | Zoom Out | Reset Zoom